ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tigecycline Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-18N9217
Home | Market Reports | Health| Pharmacy
Global Tigecycline Market Insights and Forecast to 2028
BUY CHAPTERS

Global Tigecycline Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-18N9217
Report
June 2025
Pages:149
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz Inc
Apotex
Accord Healthcare
Amneal Pharmaceuticals

Tigecycline Market Size

In 2024, the global market size of Tigecycline was estimated to be worth US$ 2004 million and is forecast to reach approximately US$ 6250 million by 2031 with a CAGR of 17.9% during the forecast period 2025-2031.

Tigecycline Market

Tigecycline Market

Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.
Global Tigecycline Sales Channel is wide, like Hospital Pharmacies , Retail Pharmacies. Hospital Pharmacies is the largest consumer channel.
Tigecycline can be mainly divided into Generic Drug, Original Drug.
In 2019, North America dominated the global Tigecycline market, accounting for more than 34% of the total revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tigecycline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tigecycline.
The Tigecycline market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tigecycline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tigecycline manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Tigecycline Market Report

Report Metric Details
Report Name Tigecycline Market
Forecasted market size in 2031 approximately US$ 6250 million
CAGR 17.9%
Forecasted years 2025 - 2031
Segment by Type
  • Original Drug
  • Generic Drug
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer (Wyeth), Sino Biopharmaceutical, Zhejiang Hisun Pharma, Jiangsu Hansoh Pharmaceutical, Abbott, Natco Pharma, Lyka Labs Limited, Fresenius Kabi, Sandoz, APOTEX, Accord Healthcare, Amneal Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Tigecycline in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Tigecycline manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tigecycline sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Tigecycline Market size in 2031?

Ans: The Tigecycline Market size in 2031 will be approximately US$ 6250 million.

What is the Tigecycline Market share by region?

Ans: In 2019, North America dominated the global Tigecycline market, accounting for more than 34% of the total revenue.

Who are the main players in the Tigecycline Market report?

Ans: The main players in the Tigecycline Market are Pfizer (Wyeth), Sino Biopharmaceutical, Zhejiang Hisun Pharma, Jiangsu Hansoh Pharmaceutical, Abbott, Natco Pharma, Lyka Labs Limited, Fresenius Kabi, Sandoz, APOTEX, Accord Healthcare, Amneal Pharmaceuticals

What are the Application segmentation covered in the Tigecycline Market report?

Ans: The Applications covered in the Tigecycline Market report are Hospital Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Tigecycline Market report?

Ans: The Types covered in the Tigecycline Market report are Original Drug, Generic Drug

1 Study Coverage
1.1 Tigecycline Product Introduction
1.2 Market by Type
1.2.1 Global Tigecycline Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Tigecycline Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tigecycline Market Size Estimates and Forecasts
2.1.1 Global Tigecycline Revenue 2020-2031
2.1.2 Global Tigecycline Sales 2020-2031
2.2 Tigecycline Market Size by Region: 2024 Versus 2031
2.3 Tigecycline Sales by Region (2020-2031)
2.3.1 Global Tigecycline Sales by Region: 2020-2025
2.3.2 Global Tigecycline Sales Forecast by Region (2026-2031)
2.3.3 Global Tigecycline Sales Market Share by Region (2020-2031)
2.4 Tigecycline Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Tigecycline Revenue by Region: 2020-2025
2.4.2 Global Tigecycline Revenue Forecast by Region (2026-2031)
2.4.3 Global Tigecycline Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Tigecycline Sales by Type (2020-2031)
3.1.1.1 Global Tigecycline Sales Volume by Type (2020-2031)
3.1.1.2 Global Tigecycline Sales Market Share by Type (2020-2031)
3.1.2 Global Tigecycline Revenue by Type (2020-2031)
3.1.2.1 Global Tigecycline Revenue by Type (2020-2031)
3.1.2.2 Global Tigecycline Revenue Market Share by Type (2020-2031)
3.1.3 Tigecycline Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Tigecycline Sales by Application (2020-2031)
3.2.1.1 Global Tigecycline Sales Volume by Application (2020-2031)
3.2.1.2 Global Tigecycline Sales Market Share by Application (2020-2031)
3.2.2 Global Tigecycline Revenue by Application (2020-2031)
3.2.2.1 Global Tigecycline Revenue by Application (2020-2031)
3.2.2.2 Global Tigecycline Revenue Market Share by Application (2020-2031)
3.2.3 Tigecycline Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Original Drug of Tigecycline Revenue Market Share by Application
3.3.2 Generic Drug of Tigecycline Revenue Market Share by Application
4 Global Tigecycline by Manufacturers
4.1 Global Top Tigecycline Manufacturers by Sales (2020-2025)
4.1.1 Global Tigecycline Sales by Manufacturer (2020-2025)
4.1.2 Global Tigecycline Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Tigecycline Manufacturers by Revenue (2020-2025)
4.2.1 Global Tigecycline Revenue by Manufacturer (2020-2025)
4.2.2 Global Tigecycline Revenue Share by Manufacturer (2020-2025)
4.3 Global Tigecycline Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Tigecycline Manufacturers Covered: Ranking by Revenue
4.4.2 Global Tigecycline Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Tigecycline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Tigecycline Manufacturing Base Distribution, Product Type
4.5.1 Tigecycline Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Tigecycline Market
4.5.3 Manufacturers Tigecycline Product Type and Application
4.5.4 Original Drug Market Sales of Tigecycline by Manufacturer
4.5.5 Generic Drug Market Sales of Tigecycline by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer (Wyeth)
5.1.1 Pfizer (Wyeth) Company Information
5.1.2 Pfizer (Wyeth) Description, Business Overview
5.1.3 Pfizer (Wyeth) Tigecycline Products Offered
5.1.4 Pfizer (Wyeth) Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer (Wyeth) Tigecycline Sales by Product in 2024
5.1.6 Pfizer (Wyeth) Tigecycline Sales by Application in 2024
5.1.7 Pfizer (Wyeth) Tigecycline Sales by Geographic Area in 2024
5.1.8 Pfizer (Wyeth) Recent Developments
5.2 Sino Biopharmaceutical
5.2.1 Sino Biopharmaceutical Company Information
5.2.2 Sino Biopharmaceutical Description, Business Overview
5.2.3 Sino Biopharmaceutical Tigecycline Products Offered
5.2.4 Sino Biopharmaceutical Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sino Biopharmaceutical Tigecycline Sales by Product in 2024
5.2.6 Sino Biopharmaceutical Tigecycline Sales by Application in 2024
5.2.7 Sino Biopharmaceutical Tigecycline Sales by Geographic Area in 2024
5.2.8 Sino Biopharmaceutical Recent Developments
5.3 Zhejiang Hisun Pharma
5.3.1 Zhejiang Hisun Pharma Company Information
5.3.2 Zhejiang Hisun Pharma Description, Business Overview
5.3.3 Zhejiang Hisun Pharma Tigecycline Products Offered
5.3.4 Zhejiang Hisun Pharma Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Zhejiang Hisun Pharma Tigecycline Sales by Product in 2024
5.3.6 Zhejiang Hisun Pharma Tigecycline Sales by Application in 2024
5.3.7 Zhejiang Hisun Pharma Tigecycline Sales by Geographic Area in 2024
5.3.8 Zhejiang Hisun Pharma Recent Developments
5.4 Jiangsu Hansoh Pharmaceutical
5.4.1 Jiangsu Hansoh Pharmaceutical Company Information
5.4.2 Jiangsu Hansoh Pharmaceutical Description, Business Overview
5.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Products Offered
5.4.4 Jiangsu Hansoh Pharmaceutical Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Jiangsu Hansoh Pharmaceutical Tigecycline Sales by Product in 2024
5.4.6 Jiangsu Hansoh Pharmaceutical Tigecycline Sales by Application in 2024
5.4.7 Jiangsu Hansoh Pharmaceutical Tigecycline Sales by Geographic Area in 2024
5.4.8 Jiangsu Hansoh Pharmaceutical Recent Developments
5.5 Abbott
5.5.1 Abbott Company Information
5.5.2 Abbott Description, Business Overview
5.5.3 Abbott Tigecycline Products Offered
5.5.4 Abbott Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Abbott Tigecycline Sales by Product in 2024
5.5.6 Abbott Tigecycline Sales by Application in 2024
5.5.7 Abbott Tigecycline Sales by Geographic Area in 2024
5.5.8 Abbott Recent Developments
5.6 Natco Pharma
5.6.1 Natco Pharma Company Information
5.6.2 Natco Pharma Description, Business Overview
5.6.3 Natco Pharma Tigecycline Products Offered
5.6.4 Natco Pharma Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Natco Pharma Tigecycline Sales by Product in 2024
5.6.6 Natco Pharma Tigecycline Sales by Application in 2024
5.6.7 Natco Pharma Tigecycline Sales by Geographic Area in 2024
5.6.8 Natco Pharma Recent Developments
5.7 Lyka Labs Limited
5.7.1 Lyka Labs Limited Company Information
5.7.2 Lyka Labs Limited Description, Business Overview
5.7.3 Lyka Labs Limited Tigecycline Products Offered
5.7.4 Lyka Labs Limited Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Lyka Labs Limited Tigecycline Sales by Product in 2024
5.7.6 Lyka Labs Limited Tigecycline Sales by Application in 2024
5.7.7 Lyka Labs Limited Tigecycline Sales by Geographic Area in 2024
5.7.8 Lyka Labs Limited Recent Developments
5.8 Fresenius Kabi
5.8.1 Fresenius Kabi Company Information
5.8.2 Fresenius Kabi Description, Business Overview
5.8.3 Fresenius Kabi Tigecycline Products Offered
5.8.4 Fresenius Kabi Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Fresenius Kabi Tigecycline Sales by Product in 2024
5.8.6 Fresenius Kabi Tigecycline Sales by Application in 2024
5.8.7 Fresenius Kabi Tigecycline Sales by Geographic Area in 2024
5.8.8 Fresenius Kabi Recent Developments
5.9 Sandoz
5.9.1 Sandoz Company Information
5.9.2 Sandoz Description, Business Overview
5.9.3 Sandoz Tigecycline Products Offered
5.9.4 Sandoz Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Sandoz Tigecycline Sales by Product in 2024
5.9.6 Sandoz Tigecycline Sales by Application in 2024
5.9.7 Sandoz Tigecycline Sales by Geographic Area in 2024
5.9.8 Sandoz Recent Developments
5.10 APOTEX
5.10.1 APOTEX Company Information
5.10.2 APOTEX Description, Business Overview
5.10.3 APOTEX Tigecycline Products Offered
5.10.4 APOTEX Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.10.5 APOTEX Tigecycline Sales by Product in 2024
5.10.6 APOTEX Tigecycline Sales by Application in 2024
5.10.7 APOTEX Tigecycline Sales by Geographic Area in 2024
5.10.8 APOTEX Recent Developments
5.11 Accord Healthcare
5.11.1 Accord Healthcare Company Information
5.11.2 Accord Healthcare Description, Business Overview
5.11.3 Accord Healthcare Tigecycline Products Offered
5.11.4 Accord Healthcare Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Accord Healthcare Tigecycline Sales by Product in 2024
5.11.6 Accord Healthcare Tigecycline Sales by Application in 2024
5.11.7 Accord Healthcare Tigecycline Sales by Geographic Area in 2024
5.11.8 Accord Healthcare Recent Developments
5.12 Amneal Pharmaceuticals
5.12.1 Amneal Pharmaceuticals Company Information
5.12.2 Amneal Pharmaceuticals Description, Business Overview
5.12.3 Amneal Pharmaceuticals Tigecycline Products Offered
5.12.4 Amneal Pharmaceuticals Tigecycline Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Amneal Pharmaceuticals Tigecycline Sales by Product in 2024
5.12.6 Amneal Pharmaceuticals Tigecycline Sales by Application in 2024
5.12.7 Amneal Pharmaceuticals Tigecycline Sales by Geographic Area in 2024
5.12.8 Amneal Pharmaceuticals Recent Developments
6 North America
6.1 North America Tigecycline Market Size YoY Growth 2020-2031
6.2 North America Tigecycline Market Facts & Figures by Country
6.2.1 North America Tigecycline Sales by Country (2020-2031)
6.2.2 North America Tigecycline Revenue by Country (2020-2031)
6.3 North America Tigecycline Sales by Type (2020-2025)
6.4 North America Tigecycline Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Tigecycline Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Tigecycline Market Facts & Figures by Region
7.2.1 Asia-Pacific Tigecycline Sales by Region (2020-2031)
7.2.2 Asia-Pacific Tigecycline Revenue by Region (2020-2031)
7.3 Asia-Pacific Tigecycline Sales by Type (2020-2025)
7.4 Asia-Pacific Tigecycline Sales by Application (2020-2025)
8 Europe
8.1 Europe Tigecycline Market Size YoY Growth 2020-2031
8.2 Europe Tigecycline Market Facts & Figures by Country
8.2.1 Europe Tigecycline Sales by Country (2020-2031)
8.2.2 Europe Tigecycline Revenue by Country (2020-2031)
8.3 Europe Tigecycline Sales by Type (2020-2025)
8.4 Europe Tigecycline Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Tigecycline Market Size YoY Growth 2020-2031
9.2 Latin America Tigecycline Market Facts & Figures by Country
9.2.1 Latin America Tigecycline Sales by Country (2020-2031)
9.2.2 Latin America Tigecycline Revenue by Country (2020-2031)
9.3 Latin America Tigecycline Sales by Type (2020-2025)
9.4 Latin America Tigecycline Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Tigecycline Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Tigecycline Market Facts & Figures by Country
10.2.1 Middle East and Africa Tigecycline Sales by Country (2020-2031)
10.2.2 Middle East and Africa Tigecycline Revenue by Country (2020-2031)
10.3 Middle East and Africa Tigecycline Sales by Type (2020-2025)
10.4 Middle East and Africa Tigecycline Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Tigecycline Supply Chain Analysis
11.2 Tigecycline Key Raw Materials and Upstream Suppliers
11.3 Tigecycline Clients Analysis
11.4 Tigecycline Sales Channel and Sales Model Analysis
11.4.1 Tigecycline Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Tigecycline Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Tigecycline Distributors
12 Tigecycline Market Dynamics
12.1 Tigecycline Industry Trends
12.2 Tigecycline Market Drivers
12.3 Tigecycline Market Challenges
12.4 Tigecycline Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz Inc
Apotex
Accord Healthcare
Amneal Pharmaceuticals
List of Tables
 Table 1. Global Tigecycline Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Tigecycline Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Tigecycline Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Tigecycline Sales by Region (2020-2025) & (K Units)
 Table 5. Global Tigecycline Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Tigecycline Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Tigecycline Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Tigecycline Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Tigecycline Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Tigecycline Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Tigecycline Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Tigecycline Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Tigecycline Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Tigecycline Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Tigecycline Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Tigecycline Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Tigecycline Sales Share by Manufacturer (2020-2025)
 Table 18. Tigecycline Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Tigecycline Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Tigecycline Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Tigecycline Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Tigecycline Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Tigecycline by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tigecycline as of 2024)
 Table 24. Tigecycline Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Tigecycline Market
 Table 26. Manufacturers Tigecycline Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Pfizer (Wyeth) Company Information
 Table 29. Pfizer (Wyeth) Description and Business Overview
 Table 30. Pfizer (Wyeth) Tigecycline Product
 Table 31. Pfizer (Wyeth) Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Pfizer (Wyeth) Sales Proportion of Tigecycline by Product in 2024
 Table 33. Pfizer (Wyeth) Sales Proportion of Tigecycline by Application in 2024
 Table 34. Pfizer (Wyeth) Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 35. Pfizer (Wyeth) Recent Developments
 Table 36. Sino Biopharmaceutical Company Information
 Table 37. Sino Biopharmaceutical Description and Business Overview
 Table 38. Sino Biopharmaceutical Tigecycline Product
 Table 39. Sino Biopharmaceutical Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Sino Biopharmaceutical Sales Proportion of Tigecycline by Product in 2024
 Table 41. Sino Biopharmaceutical Sales Proportion of Tigecycline by Application in 2024
 Table 42. Sino Biopharmaceutical Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 43. Sino Biopharmaceutical Recent Developments
 Table 44. Zhejiang Hisun Pharma Company Information
 Table 45. Zhejiang Hisun Pharma Description and Business Overview
 Table 46. Zhejiang Hisun Pharma Tigecycline Product
 Table 47. Zhejiang Hisun Pharma Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Zhejiang Hisun Pharma Sales Proportion of Tigecycline by Product in 2024
 Table 49. Zhejiang Hisun Pharma Sales Proportion of Tigecycline by Application in 2024
 Table 50. Zhejiang Hisun Pharma Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 51. Zhejiang Hisun Pharma Recent Developments
 Table 52. Jiangsu Hansoh Pharmaceutical Company Information
 Table 53. Jiangsu Hansoh Pharmaceutical Description and Business Overview
 Table 54. Jiangsu Hansoh Pharmaceutical Tigecycline Product
 Table 55. Jiangsu Hansoh Pharmaceutical Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Jiangsu Hansoh Pharmaceutical Sales Proportion of Tigecycline by Product in 2024
 Table 57. Jiangsu Hansoh Pharmaceutical Sales Proportion of Tigecycline by Application in 2024
 Table 58. Jiangsu Hansoh Pharmaceutical Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 59. Jiangsu Hansoh Pharmaceutical Recent Developments
 Table 60. Abbott Company Information
 Table 61. Abbott Description and Business Overview
 Table 62. Abbott Tigecycline Product
 Table 63. Abbott Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Abbott Sales Proportion of Tigecycline by Product in 2024
 Table 65. Abbott Sales Proportion of Tigecycline by Application in 2024
 Table 66. Abbott Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 67. Abbott Recent Developments
 Table 68. Natco Pharma Company Information
 Table 69. Natco Pharma Description and Business Overview
 Table 70. Natco Pharma Tigecycline Product
 Table 71. Natco Pharma Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Natco Pharma Sales Proportion of Tigecycline by Product in 2024
 Table 73. Natco Pharma Sales Proportion of Tigecycline by Application in 2024
 Table 74. Natco Pharma Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 75. Natco Pharma Recent Developments
 Table 76. Lyka Labs Limited Company Information
 Table 77. Lyka Labs Limited Description and Business Overview
 Table 78. Lyka Labs Limited Tigecycline Product
 Table 79. Lyka Labs Limited Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Lyka Labs Limited Sales Proportion of Tigecycline by Product in 2024
 Table 81. Lyka Labs Limited Sales Proportion of Tigecycline by Application in 2024
 Table 82. Lyka Labs Limited Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 83. Lyka Labs Limited Recent Developments
 Table 84. Fresenius Kabi Company Information
 Table 85. Fresenius Kabi Description and Business Overview
 Table 86. Fresenius Kabi Tigecycline Product
 Table 87. Fresenius Kabi Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Fresenius Kabi Sales Proportion of Tigecycline by Product in 2024
 Table 89. Fresenius Kabi Sales Proportion of Tigecycline by Application in 2024
 Table 90. Fresenius Kabi Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 91. Fresenius Kabi Recent Developments
 Table 92. Sandoz Company Information
 Table 93. Sandoz Description and Business Overview
 Table 94. Sandoz Tigecycline Product
 Table 95. Sandoz Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Sandoz Sales Proportion of Tigecycline by Product in 2024
 Table 97. Sandoz Sales Proportion of Tigecycline by Application in 2024
 Table 98. Sandoz Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 99. Sandoz Recent Developments
 Table 100. APOTEX Company Information
 Table 101. APOTEX Description and Business Overview
 Table 102. APOTEX Tigecycline Product
 Table 103. APOTEX Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. APOTEX Sales Proportion of Tigecycline by Product in 2024
 Table 105. APOTEX Sales Proportion of Tigecycline by Application in 2024
 Table 106. APOTEX Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 107. APOTEX Recent Developments
 Table 108. Accord Healthcare Company Information
 Table 109. Accord Healthcare Description and Business Overview
 Table 110. Accord Healthcare Tigecycline Product
 Table 111. Accord Healthcare Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Accord Healthcare Sales Proportion of Tigecycline by Product in 2024
 Table 113. Accord Healthcare Sales Proportion of Tigecycline by Application in 2024
 Table 114. Accord Healthcare Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 115. Accord Healthcare Recent Developments
 Table 116. Amneal Pharmaceuticals Company Information
 Table 117. Amneal Pharmaceuticals Description and Business Overview
 Table 118. Amneal Pharmaceuticals Tigecycline Product
 Table 119. Amneal Pharmaceuticals Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 120. Amneal Pharmaceuticals Sales Proportion of Tigecycline by Product in 2024
 Table 121. Amneal Pharmaceuticals Sales Proportion of Tigecycline by Application in 2024
 Table 122. Amneal Pharmaceuticals Sales Proportion of Tigecycline by Geographic Area in 2024
 Table 123. Amneal Pharmaceuticals Recent Developments
 Table 124. North America Tigecycline Sales by Country (2020-2025) & (K Units)
 Table 125. North America Tigecycline Sales by Country (2026-2031) & (K Units)
 Table 126. North America Tigecycline Revenue by Country (2020-2025) & (US$ Million)
 Table 127. North America Tigecycline Revenue by Country (2026-2031) & (US$ Million)
 Table 128. North America Tigecycline Sales by Type (2020-2025) & (K Units)
 Table 129. North America Tigecycline Sales by Application (2020-2025) & (K Units)
 Table 130. Asia-Pacific Tigecycline Sales by Region (2020-2025) & (K Units)
 Table 131. Asia-Pacific Tigecycline Sales by Region (2026-2031) & (K Units)
 Table 132. Asia-Pacific Tigecycline Revenue by Region (2020-2025) & (US$ Million)
 Table 133. Asia-Pacific Tigecycline Revenue by Region (2026-2031) & (US$ Million)
 Table 134. Asia-Pacific Tigecycline Sales by Type (2020-2025) & (K Units)
 Table 135. Asia-Pacific Tigecycline Sales by Application (2020-2025) & (K Units)
 Table 136. Europe Tigecycline Sales by Country (2020-2025) & (K Units)
 Table 137. Europe Tigecycline Sales by Country (2026-2031) & (K Units)
 Table 138. Europe Tigecycline Revenue by Country (2020-2025) & (US$ Million)
 Table 139. Europe Tigecycline Revenue by Country (2026-2031) & (US$ Million)
 Table 140. Europe Tigecycline Sales by Type (2020-2025) & (K Units)
 Table 141. Europe Tigecycline Sales by Application (2020-2025) & (K Units)
 Table 142. Latin America Tigecycline Sales by Country (2020-2025) & (K Units)
 Table 143. Latin America Tigecycline Sales by Country (2026-2031) & (K Units)
 Table 144. Latin America Tigecycline Revenue by Country (2020-2025) & (US$ Million)
 Table 145. Latin America Tigecycline Revenue by Country (2026-2031) & (US$ Million)
 Table 146. Latin America Tigecycline Sales by Type (2020-2025) & (K Units)
 Table 147. Latin America Tigecycline Sales by Application (2020-2025) & (K Units)
 Table 148. Middle East and Africa Tigecycline Sales by Country (2020-2025) & (K Units)
 Table 149. Middle East and Africa Tigecycline Sales by Country (2026-2031) & (K Units)
 Table 150. Middle East and Africa Tigecycline Revenue by Country (2020-2025) & (US$ Million)
 Table 151. Middle East and Africa Tigecycline Revenue by Country (2026-2031) & (US$ Million)
 Table 152. Middle East and Africa Tigecycline Sales by Type (2020-2025) & (K Units)
 Table 153. Middle East and Africa Tigecycline Sales by Application (2020-2025) & (K Units)
 Table 154. Tigecycline Key Raw Materials, Industry Status and Trend
 Table 155. Tigecycline Key Raw Materials and Upstream Suppliers
 Table 156. Tigecycline Clients Status and Trend
 Table 157. Tigecycline Typical Clients
 Table 158. Tigecycline Distributors
 Table 159. Tigecycline Market Trends
 Table 160. Tigecycline Market Drivers
 Table 161. Tigecycline Market Challenges
 Table 162. Tigecycline Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Tigecycline Product Picture
 Figure 2. Global Tigecycline Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Tigecycline Sales Market Share by Type in 2024 & 2031
 Figure 4. Original Drug Product Picture
 Figure 5. Generic Drug Product Picture
 Figure 6. Global Tigecycline Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Tigecycline Sales Market Share by Application in 2024 & 2031
 Figure 8. Hospital Pharmacies
 Figure 9. Retail Pharmacies
 Figure 10. Tigecycline Report Years Considered
 Figure 11. Global Tigecycline Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Tigecycline Market Size 2020-2031 (US$ Million)
 Figure 13. Global Tigecycline Sales 2020-2031 (K Units)
 Figure 14. Global Tigecycline Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global Tigecycline Revenue Market Share by Region (2020-2031)
 Figure 16. Global Tigecycline Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global Tigecycline Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Tigecycline Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 19. Global Tigecycline Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global Tigecycline Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Tigecycline Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 22. Original Drug of Tigecycline Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Generic Drug of Tigecycline Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global Tigecycline Sales Share by Manufacturer in 2024
 Figure 25. Tigecycline Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Original Drug Market Sales Proportion by Manufacturer in 2024
 Figure 27. Generic Drug Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America Tigecycline Revenue 2020-2031 (US$ Million)
 Figure 29. North America Tigecycline Sales Market Share by Type (2020-2025)
 Figure 30. North America Tigecycline Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific Tigecycline Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific Tigecycline Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific Tigecycline Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Tigecycline Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Tigecycline Sales Market Share by Application (2020-2025)
 Figure 36. Europe Tigecycline Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Tigecycline Sales Market Share by Country (2020-2031)
 Figure 38. Europe Tigecycline Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Tigecycline Sales Market Share by Type (2020-2025)
 Figure 40. Europe Tigecycline Sales Market Share by Application (2020-2025)
 Figure 41. Latin America Tigecycline Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Tigecycline Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Tigecycline Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America Tigecycline Sales Market Share by Type (2020-2025)
 Figure 45. Latin America Tigecycline Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa Tigecycline Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa Tigecycline Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Tigecycline Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Tigecycline Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa Tigecycline Sales Market Share by Application (2020-2025)
 Figure 51. Tigecycline Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of Tigecycline Raw Materials by Region in 2024
 Figure 53. Tigecycline Distribution Channels
 Figure 54. Global Tigecycline Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global Tigecycline Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Tigecycline Drug Market Insights Forecast to 2030
Global Tigecycline API Market Research Report 2025
Tygacil Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Methicillin Resistant Staphylococcus Aureus Infection Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tigecycline Injection Market Research Report 2025
Global Metacycline Market Research Report 2024
Global Tigecycline Hydrate Market Research Report 2025
Global Minocycline Hydrochloride API Market Research Report 2024
Global Methicillin Resistant Staphylococcus Aureus MRSA Treatment Market Research Report 2024
Global Tetracycline Market Research Report 2024
Global Oxytetracycline Dihydrate Market Research Report 2024
Global Linezolid Drug Market Research Report 2024
Global Chlortetracycline Market Insights Forecast to 2030
Teicoplanin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Minocycline Hydrochloride Capsules Market Research Report 2024
Global Vancomycin Market Research Report 2024
Global Tigecycline for Injection Market Research Report 2025
Global Minocycline API Market Research Report 2024
Global Doxycycline Monohydrate Reagent Market Research Report 2024
Methicillin Resistant Staphylococcus Aureus MRSA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions